Solesence, Inc. Announces Financial Results for Year Ended December 31, 2025

Key Highlights from Form 8-K Filing

• Date of Report: March 31, 2026
• Form: 8-K (Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934)
• Trading Symbol: SLSN
• Exchange: NASDAQ Capital Market
• Securities Registered: Common Stock, \$0.01 par value per share
• Shares Outstanding: 70,614,045 as of December 31, 2025

Results of Operations and Financial Condition

On March 31, 2026, Solesence, Inc. issued a press release detailing its financial performance for the year ended December 31, 2025. The press release is attached as Exhibit 99.1 to the Form 8-K and incorporated therein by reference.

Financial Overview

Notable Financial Developments

• Return to Profitability: Solesence, Inc. reported a net income of \$163,000 for 2025, marking a turnaround from a net loss of \$558,000 in 2024. This is a significant improvement and may be viewed positively by investors.
• Increase in Stockholders’ Equity: Equity increased to \$17.6 million, up from \$14.9 million, signaling strengthened financial position.
• Stable Asset Base: Total assets remained virtually unchanged year-on-year, suggesting operational stability.
• Positive EPS: Earnings per share rose to \$0.07, from a loss per share of \$0.01 previously.
• Improved Operating Income: Income from operations increased to \$186,000 from a loss of \$223,000 in 2024.
• Interest Expense: Interest expenses totaled \$328,000 in 2025, slightly lower than the prior year (\$931,000).
• Non-GAAP Disclosure: The company added back non-cash equity compensation totaling \$207,000.

Shareholder and Price-Sensitive Information

• Profitability Shift: The company’s shift from losses to profitability could be a significant catalyst for share price appreciation, as it demonstrates operational improvements and financial discipline.
• EPS Improvement: Positive EPS may attract new investors and strengthen confidence among existing shareholders.
• Increase in Equity: Growth in stockholders’ equity is a strong signal of company health and may affect valuation metrics.
• Forward-Looking Statements: The company highlighted risks related to the acceptance of engineered materials, manufacturing capacity, limited marketing experience, competitive products, dependence on patents, potential litigation, and regulatory changes. Investors should monitor these factors for future updates.
• No Emerging Growth Company Status: Solesence, Inc. does not qualify as an emerging growth company, which may impact eligibility for certain regulatory accommodations.

Additional Information

• Press Release Availability: The detailed press release is available as Exhibit 99.1 to the Form 8-K filing and contains further financial and operational details.
• Regulatory Compliance: The company remains compliant with all relevant SEC reporting obligations.
• Contact Information:
  • Media Contact: [email protected]
  • Investor Relations Contact: [email protected]

Potential Price-Moving Factors

• Return to profitability after prior losses
• Positive EPS and growth in equity
• Stable asset base and improved operating income
• Risks and uncertainties outlined in forward-looking statements

Disclaimer

This article is based on Solesence, Inc.’s Form 8-K filing and attached press release for the period ended December 31, 2025. The information is intended for informational purposes only and should not be construed as financial advice or a solicitation to buy or sell any securities. Investors are urged to review the full filings and consult with financial advisors before making any investment decisions. The company’s forward-looking statements are subject to risks and uncertainties, and actual results may differ materially.

View SOLESENCE, INC. Historical chart here